Table 1.
Patient number | Age (years) | Sex | Duration of the newest episode (months) | Duration of the illness (months) | Medication |
---|---|---|---|---|---|
1 | 68 | Female | 12 | 12 | Fluvoxamine 150 mg |
2 | 77 | Male | 3 | 3 | Mirtazapine 30 mg Electroconvulsive therapy |
3 | 77 | Female | 10 | 10 | Paroxetine 40 mg |
4 | 70 | Female | 10 | 480 | Fluvoxamine 200 mg Sulpiride 100 mg |
5 | 80 | Female | 20 | 240 | Mirtazapine 45 mg |
6 | 80 | Female | 14 | 14 | Paroxetine 40 mg |
7 | 81 | Female | 2 | 480 | Milnacipran 150 mg Sulpiride 150 mg Mirtazapine 30 mg Aripiprazole 6 mg |
8 | 79 | Female | 14 | 14 | Duloxetine hydrochloride 60 mg |
9 | 81 | Male | 2 | 48 | Sertraline 75 mg |
10 | 70 | Female | 24 | 24 | Fluvoxamine 100 mg |
11 | 69 | Female | 4 | 4 | Sertraline 50 mg |
12 | 67 | Female | 6 | 6 | Paroxetine 40 mg |
Mean (standard deviation) | 74.9 (5.6) | 13.9 (12.6) | 111.2 (184.3) |